
    
      This is a multicenter longitudinal, prospective, natural history study of patients with
      MPSIIIB designed to identify potential surrogate endpoints that may be utilized in future
      Enzyme replacement therapy (ERT) trials of MPS IIIB via defined assessments including
      standardized clinical, biochemical, neurocognitive, development, and imaging measures.
    
  